Literature DB >> 10973443

Detection and function of opioid receptors on cells from the immune system.

J M Bidlack1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10973443      PMCID： PMC95944          DOI： 10.1128/CDLI.7.5.719-723.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  67 in total

1.  Expression of kappa opioid receptors in human and monkey lymphocytes.

Authors:  L F Chuang; T K Chuang; K F Killam; Q Qiu; X R Wang; J J Lin; H F Kung; W Sheng; C Chao; L Yu
Journal:  Biochem Biophys Res Commun       Date:  1995-04-26       Impact factor: 3.575

2.  Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages.

Authors:  M Sedqi; S Roy; S Ramakrishnan; R Elde; H H Loh
Journal:  Biochem Biophys Res Commun       Date:  1995-04-17       Impact factor: 3.575

3.  Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling.

Authors:  D M Lawrence; D B Joseph; J M Bidlack
Journal:  Biochem Pharmacol       Date:  1995-01-06       Impact factor: 5.858

4.  Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: involvement of kappa opioid receptors.

Authors:  J Radulović; C Miljević; D Djergović; V Vujić; J Antić; S von Hörsten; B D Janković
Journal:  J Neuroimmunol       Date:  1995-03       Impact factor: 3.478

5.  Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation.

Authors:  K M Linner; H E Quist; B M Sharp
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

6.  Murine macrophage cell lines contain mu 3-opiate receptors.

Authors:  M H Makman; B Dvorkin; G B Stefano
Journal:  Eur J Pharmacol       Date:  1995-02-06       Impact factor: 4.432

7.  Antiproliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T cells.

Authors:  N A Shahabi; B M Sharp
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

8.  Identification of kappa opioid receptors in the immune system by indirect immunofluorescence.

Authors:  D M Lawrence; W el-Hamouly; S Archer; J F Leary; J M Bidlack
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

9.  Cloning of a human kappa opioid receptor from the brain.

Authors:  J Zhu; C Chen; J C Xue; S Kunapuli; J K DeRiel; L Y Liu-Chen
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Both T cells and macrophages are targets of kappa-opioid-induced immunosuppression.

Authors:  L Guan; R Townsend; T K Eisenstein; M W Adler; T J Rogers
Journal:  Brain Behav Immun       Date:  1994-09       Impact factor: 7.217
View more
  47 in total

1.  Effect of beta-endorphin and DAGO, a selective agonist of mu-opioid receptors, on the proliferative activity of lymphocytes.

Authors:  S V Gein; T A Simonenko; V A Chereshnev
Journal:  Dokl Biol Sci       Date:  2003 Jul-Aug

Review 2.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 3.  Opioid receptors and signaling on cells from the immune system.

Authors:  Jean M Bidlack; Maxim Khimich; Amy L Parkhill; Sarah Sumagin; Baoyong Sun; Christopher M Tipton
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-08       Impact factor: 4.147

Review 4.  Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.

Authors:  Esther M Sternberg
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

5.  Effect of dynorphin A (1-13) on lymphocyte proliferation and Thl/Th2 cytokine expression.

Authors:  S V Gein; A A Syatchikhin; S P Tendryakova
Journal:  Dokl Biol Sci       Date:  2009 Jan-Feb

6.  Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes.

Authors:  Matias Jaureguiberry-Bravo; Lillie Lopez; Joan W Berman
Journal:  J Leukoc Biol       Date:  2018-05-23       Impact factor: 4.962

7.  Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.

Authors:  Parvathi Ranganathan; Hao Chen; Miranda K Adelman; Samuel F Schluter
Journal:  J Neuroimmunol       Date:  2009-10-30       Impact factor: 3.478

8.  Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Authors:  D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

9.  CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.

Authors:  Nazira El-Hage; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-25       Impact factor: 4.147

10.  The Role of Glial Cells in Drug Abuse.

Authors:  Jose Javier Miguel-Hidalgo
Journal:  Curr Drug Abuse Rev       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.